Fatal Delayed Hemolytic Transfusion Reaction and Hyperhemolysis without Detectable Alloantibodies or Autoantibodies in a Patient with Sickle Cell Disease: A Case Report and Literature Review

Basile Nsimba^1,2*, Anoosha Habibi^3,4, France Pirenne⁵, Pablo Bartolucci^3,4, Daniel Tonduangu⁶, Christophe Duvoux⁷, Nicolas De Prost⁸, Maud Marcandetti^1,2, Armand Mekontso-Dessap⁸, Frédéric Galactéros^3,4 and Pascal Morel¹

¹Blood Bank and Immunohematology Laboratory and Haemovigilance, French Blood Establishment (EFS), France

²French Hemovigilance Network, France

³University Hospitals Henri-Mondor, Red Blood Cell Genetic Diseases Unit, France

⁴Mondor Institute for Biomedical Research, National Institute of Health and Medical Research, DHU A-TVB, Créteil, France

⁵French Establishment of the Blood, Île de France, Créteil, France

⁶Service of Medical Reanimation, Hôpital de Sens, F-89100 Sens, France

⁷Department of Hepatology, APHP, University Hospitals Henri-Mondor, Créteil, France

⁸Medical Resuscitation Service, APHP, University Hospitals Henri-Mondor, Créteil, France

^*Corresponding Author: